USPTO serial 88019740
COBALT
Reviewed by CopyMark Law Group
Status 760
- Filing date
- Status date
- Registration date
- —
- Examiner
- KEAN, AMY C
- Law office
- TMO LAW OFFICE 121
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COBALT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
West Hollywood, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
NATHANIEL L. FINTZ
NATHANIEL L. FINTZ ZUBER LAWLER LLPONE PENN PLAZA, SUITE 4430NEW YORK, NY 10119UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal herbs in dried or preserved form, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Medicinal herbs in dried or preserved form, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing, as an inactive ingredient, CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods not conforming to an OTC Monograph; Medicinal herbs in dried or preserved form, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Medicinal herbs in dried or preserved form, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids; Medicinal herb extracts, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Medicinal herb extracts, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing, as an inactive ingredient, CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods not conforming to an OTC Monograph; Medicinal herb extracts, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Medicinal herb extracts, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids; Medicinal oils, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Medicinal oils, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing, as an inactive ingredient, CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods not conforming to an OTC Monograph; Medicinal oils, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Medicinal oils, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids | ACTIVE | — |
| 030 | Dried herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Dried herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Dried herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing hemp seeds, hemp seed protein powder, or hemp seed oil; Dried herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids; Processed herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Processed herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Processed herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing hemp seeds, hemp seed protein powder, or hemp seed oil; Processed herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids | ACTIVE | — |
| 031 | Fresh herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Fresh herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Fresh herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing hemp seeds, hemp seed protein powder, or hemp seed oil; Fresh herbs, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 16, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 24, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 24, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 24, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 22, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 22, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 22, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 27, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 27, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 27, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 5, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 9, 2020 | ALIE | ASSIGNED TO LIE | — |
| Dec 17, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 24, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 5, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2018 | NWAP | NEW APPLICATION ENTERED | — |